More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.36B
EPS
1.32
P/E ratio
89.9
Price to sales
5.19
Dividend yield
--
Beta
1.709528
Previous close
$114.40
Today's open
$115.38
Day's range
$111.99 - $115.76
52 week range
$98.27 - $176.38
show more
CEO
Matthijs Glastra
Employees
3000
Headquarters
Bedford, MA
Exchange
Nasdaq Global Select
Shares outstanding
37821859
Issue type
Common Stock
Technology
Hardware & Equipment
What Novanta (NOVT) Said on Its Q3 Earnings Call
Novanta NASDAQ: NOVT reported third-quarter revenue growth of 23% and its strongest organic growth in more than three years, as demand for robotics and advanced manufacturing products helped offset weakness in precision medicine. The company also completed its largest acquisition, Riverpoint Medical.
MarketBeat • Nov 10, 2026

Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript
Novanta Inc. ( NOVT ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST Company Participants Marcella Meditz Matthijs Glastra - CEO & Chairman of the Board John Lesica - Co-Chief Operating Officer of Medical Solutions Charles Ravetto - Co-Chief Operating Officer of Automation Enabling Technologies Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities, Inc. Brian Drab - William Blair & Company L.L.C., Research Division Presentation Operator Good morning.
Seeking Alpha • Nov 10, 2026

Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, in London. About Novanta Novanta is a leading global supplier of core technology solutions that g.
Business Wire • Nov 10, 2026

Novanta Announces Financial Results for the Third Quarter 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) October 2, September 26, 2026 2025 GAAP Revenue $ 305.0 $ 247.8 Operating Income $ 13.9 $ 21.8 Net Income $ 2.0 $ 10.7 Diluted EPS $ 0.05 .
Business Wire • Nov 9, 2026

Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates
Novanta (NOVT) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.87 per share a year ago.
Zacks Investment Research • Nov 10, 2026

Baron Discovery Fund Q3 2026 Portfolio Activity
During the quarter, we initiated a position in Jersey Mike's Subs Inc., a franchisor of fast casual, submarine-style sandwich restaurants. We participated in the IPO of Lyntris Inc., a fast-growing proprietary defense solutions provider with a 90% sole-sourced portfolio exposed to many of the nation's key defense offerings. We sold our position in Wingstop Inc. during the quarter to allocate the proceeds into other restaurant companies where we felt there was better upside potential.
Seeking Alpha • Nov 4, 2026

Human Data, Robot Hands: Where Automation Goes Next
High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.
ETF Trends • Oct 21, 2026

Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that giv.
Business Wire • Oct 20, 2026

How to Invest in AI Drug Discovery
.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.
ETF Trends • Oct 14, 2026

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf.
Business Wire • Oct 13, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Novanta Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.